TACSTD2 and cervical carcinoma: Trop-2 is typically expressed in cervical cancer, particularly in squamous cell carcinoma, but is not expressed in normal cervical tissues (Zeybek et al., 2020; Chiba et al., 2024; Varughese et al., 2011).